Showing results (121-130 of 4,701) with videos related to
Sort By:
Pageof 471
Therapeutic Drug Monitoring|May 27, 2003
Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assayMalka Britzi, Stefan Soback, Nina Isoherranen, et al.Therapeutic Drug Monitoring|May 27, 2003
How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples?Jesús Hermida, J Carlos TutorTherapeutic Drug Monitoring|January 22, 2002
Pharmacokinetic and other drug interactions in patients with AIDSA Dasgupta, P C OkhuysenTherapeutic Drug Monitoring|January 22, 2002
Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypesA LLerena, R Berecz, A de la Rubia, et al.Therapeutic Drug Monitoring|January 22, 2002
Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approachM Contin, R Riva, P Martinelli, et al.Therapeutic Drug Monitoring|January 22, 2002
Population pharmacokinetics of perhexiline from very sparse, routine monitoring dataR Hussein, B G Charles, R G Morris, et al.Therapeutic Drug Monitoring|January 22, 2002
Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantationE Zylber-Katz, E GranotTherapeutic Drug Monitoring|January 22, 2002
Methsuximide reduces valproic acid serum levelsF M Besag, D J Berry, M VaseyTherapeutic Drug Monitoring|January 22, 2002
Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence studyC H de Oliveira, R E Barrientos-Astigarraga, M O de Moraes, et al.Therapeutic Drug Monitoring|September 28, 2002
Optimizing the hydrolysis of codeine and morphine glucuronides in urineL Peter Hackett, Leon J Dusci, Kenneth F Ilett, et al.Pageof 471